Tuesday Morning, April 26,1955
9:00 A.M. Scientific Session: REGULAR PROGRAM.
32. Pulmonary Resection in
Active Cavitary (Open-Positive) Tuberculosis.
Robert H. Holland (by invitation), John W. Bell (by invitation) and
Edward S. Welles, Sunmount, N. Y.
Current attempts to control cavitary tuberculosis with
prolonged chemotherapy result in a predictable incidence of medical failures.
When a resistant strain of tubercle bacilli develops, definitive surgical
treatment is followed by a high incidence of major complications.
This study deals with over eighty resections in
patients who had positive sputa or gastric washings, and cavities visible on
planigrams immediately prior to surgery. Studies of bacterial sensitivity to
Streptomycin, Para-Amino-Salicylic Acid and Isoniazid are available on
admission, preoperatively and postoperatively. Accordingly, we have divided
these cases into Original Chemotherapy (Susceptible and Resistant) and
Retreatment Chemotherapy (Susceptible and Resistant). A number of patients in
the Retreatment-Resistant group were given short term pre and postoperative
courses of viomycin and terramycin in combination. These four groups have been
studied from admission, through surgery, and on follow-up examinations.
It is felt that medical failure can be anticipated in
the early months of chemotherapy when certain indications exist. These
indications are presented, together with recommendations for earlier surgical
treatment.
33. Simultaneous Bilateral
Resection for Pulmonary Tuberculosis in Mental Patients.
F. John Lewis, M. Taufic (by invitation), B. Zimmerman (by invitation),
Morley Cohen (by invitation) and
J. F. Perry (by invitation),
Minneapolis, Minn.
In 14 patients with bilateral pulmonary tuberculosis we
have resected parts of both lungs at one operation. The operation has been done
through an anterior incision with transverse division of the sternum and entry
into both pleural cavities through the third interspaces. Diseased segments in
both lungs were then removed sequentually by one operating team, or at the same
time with two. The former method is preferred. A lobectomy on one side plus a
segmental resection on the opposite side was necessary in one patient while the
others all had bilateral segmental resections. There were no deaths. The
patients were all inmates of a State Mental Hospital and they were in
relatively good health except for their tuberculosis.
For these particular patients, and perhaps for others
as well, this method has several advantages over the staged bilateral
resection. The total time of treatment can be shortened by 9 to 12 months and
we have been able to attend more expeditiously to the long list of mental
patients with tuberculosis who are awaiting surgery. For most of the patients
the operation has been no harder to bear than the second operation of a staged
bilateral resection. Perhaps this is because a simultaneous bilateral operation
forces a more uniform distribution of the respiratory load postoperatively.
Then, too, with a bilateral anterior incision there is less muscle trauma and
disability than with either side of a staged procedure. We plan to continue
using the simultaneous operation for good risk patients with limited bilateral
disease.
34. Blood Volume Studies in
Pulmonary Tuberculosis.
John H. Kehne (by invitation) and Felix A. Hughes, Memphis, Tenn.
Previously published reports indicate the importance of
blood volume deficiencies in the chronically ill patient but limited work has
been done specifically in the field of tuberculosis. Significant replaceable
deficiencies in blood volume, plasma volume and hemoglobin mass have been found
in 62% of an unselected survey series of 100 cases of pulmonary tuberculosis
presented as candidates for thoracic surgery. Average deficiencies found were 12%
in blood volume, 19% in hemoglobin mass and 9% in plasma volume. The deficiency
in the hemoglobin mass was found to exceed 500 cc. of whole blood in 62% of the
total series, 1000 cc. of blood in 46% of the series, and 1.500 cc. of blood in
23% of the entire group.
Blood volume determinations represent the only method
to evaluate these deficiencies and should be employed more frequently in
chronic pulmonary tuberculosis in order to provide better supportive therapy in
both the medical and surgical phases of treatment. Considering the fact that
these patients had been under treatment in different hospitals for prolonged
periods and assumed to be normal, the problem of blood deficiencies should be
presented and re-evaluated.
35. Surgical Treatment in Tuberculosis Complicated with Pulmonary
Emphysema.
Robert W. Newman, Perry M. Huggin, Charles L. Butler and
Medford C.
Bowman (all by invitation), Knoxville,
Tenn.
The authors have been
impressed that surgical treatment in patients with tuberculosis complicated by
pulmonary emphysema is much more hazardous both as to the operative and to the
postoperative course. Since the majority of surgery in tuberculosis is now
excisional in nature, a study of results comparing emphysematous tuberculous
patients with non-emphysematous patients would be helpful.
The presentation is an analysis of 30 surgical patients
with pulmonary tuberculosis complicated by moderate to severe generalized
emphysema. A concept of the pathology involved and the rationale of surgical
approach is presented. The complications, morbidity and mortality in these 30
patients are compared to a group of 259 surgical patients treated during the
same period who had pulmonary tuberculosis without complicating emphysema. A
discussion of the postoperative problem of the "emphysema syndrome" is
presented and recommendations as to the prevention of its development are made.
Physiological data is presented relative to the
preoperative diagnosis and evaluation of this group of patients with
complicated tuberculosis. A discussion of the decisions as to the best surgical
approach to treatment in the light of our experiences with the problem is
presented.
36. Surgery for Cavitary
Tuberculosis in Patients with a Single Lung.
Francis M.
Woods and Norman J. Wilson, Boston,
Mass.
Control of cavitary tuberculosis in the single
remaining lung has been nearly insuperable when rest and anti-microbial agents
fail. Pneumothorax, both intra and extrapleural, modified thoracoplasty,
pneumoperitoneum, cavity drainage have all been tried. Resection remains the
surest method when applicable. We have removed segments or single lobes in the
lung remaining after pneumonectomy in seven instances since 1951. Only one
operative mortality occurred. The problems of case selection, anesthesia,
technical difficulties at operation, the postoperative management and the
favorable end results will be reported. Some physiologically similar situations
will also be discussed where the active disease is in the lung opposite a
totally destroyed lung.
37. Surgical Treatment of Pulmonary Histoplasmosis with MRD-112 as an
Adjunct.
John W. Polk (by invitation), Chas. A. Brasher (by invitation),
Joao De Castro (by invitation) and
W. W. Buckingham, Kansas City,
Mo.
A brief history of histoplasmosis is described.
Detailed pathological findings in resected and autopsy specimens are
considered. The methods of treating pulmonary histoplasmosis are discussed with
emphasis on surgical resection and the use of MRD-112. Experiences with
surgical resection in four patients having chronic, progressive, pulmonary
histoplasmosis are discussed. The organism, Histoplasma Capsulatum, was
cultured in each case. One case resected without drug therapy is reviewed in
detail; a second case treated with MRD-112 prior to thoracotomy is also
outlined. In contrast, cases of four patients treated medically with MRD-112
are outlined.
All cases have been followed thoroughly to determine
the benefits of each form of therapy. The role of complement fixation
determination, in both surgical and medical treatment, is discussed fully.
These experiences with chronic, progressive, pulmonary histoplasmosis led us to
believe that it is a generalized disease, similar in many ways to tuberculosis.
It is believed that for localized, chronic disease, surgical resection offers
the best prognosis. Treatment with MRD-112 has been utilized in cases with
extensive pulmonary disease. Follow-up studies will be needed before the final
evaluation of this drug can be ascertained. Surgical resection may be used for
destroyed areas of lung following MRD-112 treatment. We propose that careful
complement fixation data offers the best method of following post-treatment
cases.